Cancer Stem Cells: Emergent Nature of Tumor Emergency

por Efremov, Yaroslav R., Proskurina, Anastasia S., Potter, Ekaterina A., Dolgova, Evgenia V., Efremova, Oksana V., Taranov, Oleg S., Ostanin, Aleksandr A., Chernykh, Elena R., Kolchanov, Nikolay A., Bogachev, Sergey S.
Publicado 2018

Efficacy of a new cancer treatment strategy based on eradication of tumor-initiating stem cells in a mouse model of Krebs-2 solid adenocarcinoma

por Potter, Ekaterina A., Proskurina, Anastasia S., Ritter, Genrikh S., Dolgova, Evgenia V., Nikolin, Valeriy P., Popova, Nelly A., Taranov, Oleg S., Efremov, Yaroslav R., Bayborodin, Sergey I., Ostanin, Aleksandr A., Chernykh, Elena R., Kolchanov, Nikolay A., Bogachev, Sergey S.
Publicado 2018

Combined therapy with cyclophosphamide and DNA preparation inhibits the tumor growth in mice

por Alyamkina, Ekaterina A, Dolgova, Evgenia V, Likhacheva, Anastasia S, Rogachev, Vladimir A, Sebeleva, Tamara E, Nikolin, Valeriy P, Popova, Nelly A, Orishchenko, Konstantin E, Strunkin, Dmitriy N, Chernykh, Elena R, Zagrebelniy, Stanislav N, Bogachev, Sergei S, Shurdov, Mikhail A
Publicado 2009

Karanahan: A Potential New Treatment Option for Human Breast Cancer and Its Validation in a Clinical Setting

por Proskurina, Anastasia S, Kupina, Victoria V, Efremov, Yaroslav R, Dolgova, Evgenia V, Ruzanova, Vera S, Ritter, Genrikh S, Potter, Ekaterina A, Kirikovich, Svetlana S, Levites, Evgeniy V, Ostanin, Alexandr A, Chernykh, Elena R, Babaeva, Oksana G, Sidorov, Sergey V, Bogachev, Sergey S
Publicado 2022

A strategy of tumor treatment in mice with doxorubicin-cyclophosphamide combination based on dendritic cell activation by human double-stranded DNA preparation

por Alyamkina, Ekaterina A, Nikolin, Valeriy P, Popova, Nelly A, Dolgova, Evgenia V, Proskurina, Anastasia S, Orishchenko, Konstantin E, Efremov, Yaroslav R, Chernykh, Elena R, Ostanin, Alexandr A, Sidorov, Sergey V, Ponomarenko, Dmitriy M, Zagrebelniy, Stanislav N, Bogachev, Sergey S, Shurdov, Mikhail A
Publicado 2010

A strategy to eradicate well-developed Krebs-2 ascites in mice

por Potter, Ekaterina A., Dolgova, Evgenia V., Proskurina, Anastasia S., Minkevich, Alexandra M., Efremov, Yaroslav R., Taranov, Oleg S., Omigov, Vladimir V., Nikolin, Valeriy P., Popova, Nelly A., Bayborodin, Sergey I., Ostanin, Alexander A., Chernykh, Elena R., Kolchanov, Nikolay A., Shurdov, Mikhail A., Bogachev, Sergey S.
Publicado 2016

Gene expression profiling of tumor-initiating stem cells from mouse Krebs-2 carcinoma using a novel marker of poorly differentiated cells

por Potter, Ekaterina A., Dolgova, Evgenia V., Proskurina, Anastasia S., Efremov, Yaroslav R., Minkevich, Alexandra M., Rozanov, Aleksey S., Peltek, Sergey E., Nikolin, Valeriy P., Popova, Nelly A., Seledtsov, Igor A., Molodtsov, Vladimir V., Zavyalov, Evgeniy L, Taranov, Oleg S., Baiborodin, Sergey I., Ostanin, Alexander A., Chernykh, Elena R., Kolchanov, Nikolay A., Bogachev, Sergey S.
Publicado 2016

Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the adaptive immune...

por Proskurina, Anastasia S, Gvozdeva, Tatiana S, Alyamkina, Ekaterina A, Dolgova, Evgenia V, Orishchenko, Konstantin E, Nikolin, Valeriy P, Popova, Nelly A, Sidorov, Sergey V, Chernykh, Elena R, Ostanin, Alexandr A, Leplina, Olga Y, Dvornichenko, Victoria V, Ponomarenko, Dmitriy M, Soldatova, Galina S, Varaksin, Nikolay A, Ryabicheva, Tatiana G, Zagrebelniy, Stanislav N, Rogachev, Vladimir A, Bogachev, Sergey S, Shurdov, Mikhail A
Publicado 2015

Combination of cyclophosphamide and double-stranded DNA demonstrates synergistic toxicity against established xenografts

por Alyamkina, Ekaterina A, Nikolin, Valeriy P, Popova, Nelly A, Minkevich, Alexandra M, Kozel, Artem V, Dolgova, Evgenia V, Efremov, Yaroslav R, Bayborodin, Sergey I, Andrushkevich, Oleg M, Taranov, Oleg S, Omigov, Vladimir V, Rogachev, Vladimir A, Proskurina, Anastasia S, Vereschagin, Evgeniy I, Kiseleva, Elena V, Zhukova, Maria V, Ostanin, Alexandr A, Chernykh, Elena R, Bogachev, Sergey S, Shurdov, Mikhail A
Publicado 2015

Erratum to: Results of multicenter double-blind placebo-controlled phase II clinical trial of Panagen preparation to evaluate its leukostimulatory activity and formation of the ada...

por Proskurina, Anastasia S., Gvozdeva, Tatiana S., Alyamkina, Ekaterina A., Dolgova, Evgenia V., Orishchenko, Konstantin E., Nikolin, Valeriy P., Popova, Nelly A., Sidorov, Sergey V., Chernykh, Elena R., Ostanin, Alexandr A., Leplina, Olga Y., Dvornichenko, Victoria V., Ponomarenko, Dmitriy M., Soldatova, Galina S., Varaksin, Nikolay A., Ryabicheva, Tatiana G., Uchakin, Peter N., Zagrebelniy, Stanislav N., Rogachev, Vladimir A., Bogachev, Sergey S., Shurdov, Mikhail A.
Publicado 2016

Five-year disease-free survival among stage II-IV breast cancer patients receiving FAC and AC chemotherapy in phase II clinical trials of Panagen

por Proskurina, Anastasia S., Gvozdeva, Tatiana S., Potter, Ekaterina A., Dolgova, Evgenia V., Orishchenko, Konstantin E., Nikolin, Valeriy P., Popova, Nelly A., Sidorov, Sergey V., Chernykh, Elena R., Ostanin, Alexandr A., Leplina, Olga Y., Dvornichenko, Victoria V., Ponomarenko, Dmitriy M., Soldatova, Galina S., Varaksin, Nikolay A., Ryabicheva, Tatiana G., Uchakin, Peter N., Rogachev, Vladimir A., Shurdov, Mikhail A., Bogachev, Sergey S.
Publicado 2016

Identification of cancer stem cells and a strategy for their elimination

por Dolgova, Evgenia V, Alyamkina, Ekaterina A, Efremov, Yaroslav R, Nikolin, Valeriy P, Popova, Nelly A, Tyrinova, Tamara V, Kozel, Artem V, Minkevich, Alexandra M, Andrushkevich, Oleg M, Zavyalov, Evgeniy L, Romaschenko, Alexander V, Bayborodin, Sergey I, Taranov, Oleg S, Omigov, Vladimir V, Shevela, Ekaterina Ya, Stupak, Vyacheslav V, Mishinov, Sergey V, Rogachev, Vladimir A, Proskurina, Anastasia S, Mayorov, Vladimir I, Shurdov, Mikhail A, Ostanin, Alexander A, Chernykh, Elena R, Bogachev, Sergey S
Publicado 2014